RxDoctor Payments Data

Benyamine Mizrahi, MD

Colon & Rectal Surgery · Overland Park, KSNPI 1902095805

Payments from drug & device makers

What this record shows

This record is dominated by education: $62,250 of the $87,768 with a category attached, or 70.9%. Intuitive Surgical accounts for 91.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $37,054 and has fallen 90.7% since, to $3,433 in 2025.

$87,768in general payments, 2019–2025

Across 186 payments — averaging $471.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$80K
  • TELA Bio, Inc.$5K
  • Sanara Medtech Inc.$2K
  • Stryker$175
  • Acera Surgical, Inc.$160
  • Medtronic$151
  • plus $571 from 7 others

What the payments were for

  • Consulting fees$2,2503%
  • Speaking & faculty fees$5,5006%
  • Travel & lodging$10,39412%
  • Food & beverage$7,1768%
  • Education$62,25071%
  • Gifts$1990%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few colon & rectal surgery providers in Kansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$234,524
Medicare patients
374
Services billed
1,004

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Colestipol Hcl26$1,559
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine23$1,496
PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C11$1,432
Neomycin Sulfate57$148
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$123
Diazepam15$85
Metronidazole59$73
Metoclopramide Hcl55$27

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Overland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →